Influenza A Virus NS1 Protein Prevents Activation of NF-κB and Induction of Alpha/Beta Interferon
By Xiuyan Wang, Ming Li, Hongyong Zheng, T. Muster, P. Palese, A. Beg, A. García‐Sastre. Journal of Virology, 2000
604 citations recorded by the source corpus.
Subfields: Immunology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/cc1647c36896377ea12fa3a6eec8410d8e509770
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
- R. Randall
- S. Goodbourn
- A. García‐Sastre
- F. Weber
- J. Rehwinkel
- C. Reis e Sousa
- D. Goubau
- Shizuo Akira
In Molecular Biology
Citations in the corpus
- The interferon response circuit: Induction and suppression by pathogenic viruses (2005, background): “…not only binds to and sequesters dsRNA molecules to prevent induction of IFNs (Garcia-Sastre, 2001; Garcia-Sastre et al., 1998; Talon et al., 2000a; Wang et al., 2000) but also inhibits the 3V end processing of cellular pre-mRNAs, regulates the virus replica- tion cycle and enhances translation…”
- Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. (2008, background): “, 2007), it may also play an important role in preventing dsRNA-mediated induction of IFN (Talon et al., 2000a; Wang et al., 2000; Li et al., 2006b).”
- The multifunctional NS1 protein of influenza A viruses. (2008, methodology): “Studies using PR8/NS1 demonstrated that this protein prevents dsRNA- and virus-mediated activation of the IRF-3, NFkB and c-Jun/ATF-2 transcription factors, which are otherwise essential for IFN-b induction (Ludwig et al., 2002; Talon et al., 2000a; Wang et al., 2000).”
- Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by RIG-I (2009, background): “, 2000), NFκB (Wang et al., 2000), and ATF-2/c-Jun (Ludwig et al.”
- RIG-I detects viral genomic RNA during negative-strand RNA virus infection. (2010, methodology): “To capture the physiologically relevant RIG-I agonist during SeV infection, we again made use of flu NS1, which is able to inhibit IFN responses to SeV (Wang et al., 2000).”